Rhabdomyolysis among acute human poisoning cases

Human and Experimental Toxicology

Volumn 26, Issue 7, 2007, Pages 557-561

  Talaie, Haleh ^a   Pajouhmand, A ^a   Abdollahi, M ^b   Panahandeh, R ^a   Emami, H ^c   Hajinasrolah, S ^c   Tghaddosinezhad, M ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemical; Drug; Poisoning; Rhabdomyolysis

Indexed keywords

BILIRUBIN GLUCURONIDE; CREATINE KINASE; LACTATE DEHYDROGENASE; MYOGLOBIN; OPIATE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; CREATINE KINASE BLOOD LEVEL; DRUG INTOXICATION; FEMALE; HUMAN; IRAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUSCLE RIGIDITY; MYALGIA; MYOSITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHABDOMYOLYSIS;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CREATINE KINASE; FEMALE; HUMANS; INCIDENCE; IRAN; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; POISON CONTROL CENTERS; POISONING; RHABDOMYOLYSIS;

EID: 34548418402     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107078667     Document Type: Article

References (32)

1. Seger DL. Common complications in critically poisoned patient. In Brent J, Wallace KL, Burkhart KK eds. Critical care toxicology. Mosby, 2005: 80-82.
2. Guis S, Mattei JP, Cozzone PJ, Bendahan D. Pathophysiology and clinical presentations of rhabdomyolysis. Joint Bone Spine 2005; 72: 382-91.
3. Bywaters EG, Beall D. Crush injuries with impairment of renal function. J Am Soc Nephrol 1998; 9: 322-32.
4. Lichtstein DM, Arteaga RB. Rhabdomyolysis associated with hyperthyroidism. Am J Med Sci 2006; 332: 103-105.
5. Singh D, Chander V, Chopra K. Rhabdomyolysis. Methods Find Exp Clin Pharmacol 2005; 27: 39-48.
6. Leone J, Hamon R, Borella C et al. Rhabdomyolysis complicating acute lumbar compartment syndrom. Rev Rhum Ed Fr 1994; 61: 865-67.
7. Holt S, Reeder B, Wilson M et al. Increased lipid peroxidation in patients with rhabdomyolysis. Lancet 1999; 353: 1241.
8. Szewczyk D, Ovadia P, Abdullah F, Rabinovici R. Pressure-induced rhabdomyolysis and acute renal failure. J Trauma 1998; 44: 384-88.
9. Walls M. Orthopedic trauma! RN 2002; 65: 52-56.
10. Black C, Jick H. Etiology and frequency of rhabdomyolysis. Pharmacotherapy 2002; 22: 1524-26.
11. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 2005; 84: 377-85.
12. Lane R, Phillips M. Rhabdomyolysis. Br Med J 2003; 327: 115-16.
13. Meister J, Reddy K. Rhabdomyolysis: an overview. Am J Nurs 2002; 102: 75, 77, 79.
14. Russell TA. Acute renal failure related to rhabdomyolysis: pathophysiology, diagnosis, and collaborative management. Nephrol Nurs J 2005; 32: 409-17.
15. Dhawan R, Jyothinagaram MG, Schwartz AB. 1997. Pathogenesis and management of rhabdomyolysis. Available at http://webcampus.drexelmed.edu/cme/ monographs/MonographsDescription.asp? Series = 0702.
16. David WS. Myoglobinuria. Neurol Clin 2000; 18: 215-43.
17. Qadir F, Ahmadani Y, Masood Q. Severe rhabdomyolysis due to drug overdose. J Coll Physicians Surg Pak 2004; 14: 436-37.
18. Koppel C. Clinical features, pathogenesis and management of drug-induced rhabdomyolysis. Med Toxicol Adverse Drug Exp 1989; 4: 108-26.
19. Lappalainen H, Tiula E, Uotila L, Manttari M. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Crit Care Med 2002; 30: 2212-15.
20. Poels PJ, Gabreels FJ. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993; 95: 175-92.
21. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982; 61: 141-52.
22. Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem 2000; 37: 581-87.
23. Feinfeld DA, Cheng JT, Beysolow TD, Briscoe AM. A prospective study of urine and serum myoglobin levels in patients with acute rhabdomyolysis. Clin Nephrol 1992; 38: 193-95.
24. Laios ID, Caruk R, Wu AH. Myoglobin clearance as an early indicator for rhabdomyolysis-induced acute renal failure. Ann Clin Lab Sci 1995; 25: 179-84.
25. Veenstra J, Smit WM, Krediet RT, Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant 1994; 9: 637-41.
26. Bostanjian D, Anthone GJ, Hamoui N, Crookes PR Rhabdomyolysis of gluteal muscles leading to renal failure: a potentially fatal complication of surgery in the morbidly obese. Obes Surg 2003; 13: 302-305.
27. Schulze VE Jr. Rhabdomyolysis as a cause of acute renal failure. Postgrad Med 1982; 72: 145-47, 150-58.
28. Knochel JP. Mechanisms of rhabdomyolysis. Curr Opin Rheumatol 1993; 5: 725-31.
29. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve 2002; 25: 332-47.
30. Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie II. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med 1988; 319: 673-77.
31. Fine DM, Gelber AC, Melamed ML, Lin JC, Zhang L, Eustace JA. Risk factors for renal failure among 72 consecutive patients with rhabdomyolysis related to illicit drug use. Am J Med 2004; 117: 607-10.
32. Akmal M, Massry SG. Reversible hepatic dysfunction associated with rhabdomyolysis. Am J Nephrol 1990; 10: 49-52.